A monoclonal antibody treatment for Alzheimer's disease called lecanemab slows the progression of cognitive decline by 2
TipMeACoffeebeta
Ask TipMeACoffee AI
Latest on TipMeACoffee AI
More AI Answers
A monoclonal antibody treatment for Alzheimer's disease called lecanemab slows the progression of cognitive decline by 2